Characterization, cloning and expression of the Tage4 gene, a member of the immunoglobulin superfamily (Review)

International Journal of Oncology

Volumn 12, Issue 5, 1998, Pages 997-1005

  Denis, Marc G ^a  

^a INSTITUT DE BIOLOGIE   (France)

Author keywords

Immunoglobulin superfamily; Tage4 gene

Indexed keywords

IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

AMINO ACID SEQUENCE; CANCER CELL CULTURE; CHROMOSOME 19Q; COLON CARCINOMA; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENE LOCATION; HUMAN; IMMUNOFLUORESCENCE TEST; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

EID: 0031955666     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Moertel CG, Fleming TR, MacDonald JS, Haller DG, Laurie JA and Tangen C: An evaluation of the carcino-embryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 270: 943-947, 1993.
2. Ballesta AM, Molina R, Filella X, Jo J and Gimenez N: Carcinoembryonic antigen in staging and follow-up of patients with solid tumors. Tumor Biol 16: 32-41, 1995.
3. Markman M: CEA monitoring after primary therapy for colon cancer. J Cancer Res Clin Oncol 121: 385-386, 1995.
4. Northover J, Houghton J and Lennon T: CEA to detect recurrence of colon cancer. JAMA 272: 31, 1994.
5. Kouri M, Nordling S, Kuusela P and Pyrhonen S: Poor prognosis associated with elevated serum CA 19-9 level in advanced colorectal carcinoma, independent of DNA ploidy or SPF. Eur J Cancer 29 A: 1691-1696, 1993.
6. Diez M, Cerdan FJ, Pollan M, Maestro ML, Ortega MD, Martinez S, Moreno G and Balibrea JL: Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma. Anticancer Res 14: 2819-2825, 1994.
7. Yuceyar S, Erturk S, Dirican A, Cengiz A and Saner H: The role of acute-phase reactant proteins, carcinoembryonic antigen and CA 19-9 as a marker in the preoperative staging of colorectal cancer: a prospective clinical study. Int Surg 81: 136-139, 1996.
8. Guadagni F, Roselli M, Cosimelli M, Mannella E, Tedesco M, Cavaliere F, Grassi A, Abbolito MR, Greiner JW and Schlom J: TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer. Cancer 72: 2098-2106, 1993.
9. Guadagni F, Roselli M, Cosimelli M, Ferroni P, Spila A, Cavaliere F, Arcuri R, Carlini S, Mariotti S, Gandolfo GM, Casciani CLJ, Greiner JW and Schlom J: TAG-72 expression and its role in the biological evaluation of human colorectal cancer. Anticancer Res 16: 2141-2148, 1996.
10. Vijayakumar V, Blend MJ, Johnson D, Schnobrich K and Golick J: Detection of recurrent colon cancer with In-111 labeled MoAb B72.3 in a patient with normal CEA and TAG-72 levels. Clin Nucl Med 17: 180-184, 1992.
11. Vijayakumar V, Blend MJ, Johnson DK, Seevers RH, Schnobrich KE, Bekerman C: Improved detection of hepatic lesions using MoAb B72.3 and a modified 111 In labelling technique in patients with recurrent colon cancer. Nucl Med Commun 14: 658-666, 1993.
12. Riethmuller G, Schneider-Gadicke E, Schlimok G, Schmiegel W, Raab R, Hoffken K Gruber R, Pichlmaier H, Hirche H and Pichlmayr R: Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. Lancet 343: 1177-1183, 1994.
13. Juhl H, Stritzel M, Wroblewski A, Henne-Bruns D, Kremer B, Schgmiegel W, Neumaier M, Wagener C, Schreiber HW and Kalthoff H: Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer 57: 330-335, 1994.
14. Meredith RF, Khazaeli MB, Plott WE, Spencer SA, Wheeler RH, Brady LW, Woo DV and Lobuglio AF: Initial clinical evaluation of iodine-125-labeled chimeric 17-1A for metastatic colon cancer. J Nucl Med 36: 2229-2233, 1995.
15. Schlimok G, Funke I, Holzmann B, Gottlinger G, Schmidt G, Hauser H, Swierkot S, Warnecke HH, Schneider B and Koprowski H: Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1 A monoclonal antibodies. Proc Natl Acad Sci USA 84: 8672-8676, 1987.
16. Martin F, Caignard A, Jeannin JF, Leclerc A and Martin M: Selection by trypsin of two sublines of rat colon cancer cells forming progressive or regressive tumors. Int J Cancer 32: 623-627, 1983.
17. Douillard JY, Laborda J, Burg C, Ridge J, Levenbook I, Blottière H, Ben Ami S and Hoffman T: Monoclonal antibodies to a rat colon carcinoma: model for monoclonal antibody therapy of solid tumors. Cancer Res 49: 687-692, 1989.
18. Zennadi R, Garrigue L, Ringeard S, Menoret A, Blanchardie P and Le Pendu J: Analysis of factors associated with the tumorigenic potential of 12 tumor clones derived from a single rat colon adenocarcinoma. Int J Cancer 52: 934-940, 1992.
19. Chadéneau C, Denis MG, Blottière HM, Grégoire M, Douillard JY and Meflah K: Characterization, isolation and amino terminal sequencing of a rat colon carcinoma-associated antigen. Int J Cancer 47: 903-908, 1991.
20. Decaens C, Gautier R, Bara J, Daher N, Le Pendu J and Burtin P: A new mucin-associated oncofetal antigen, a marker of early carcinogenesis in rat colon. Cancer Res 48: 1571-1577, 1988.
21. Decaens C, Gautier R, Daher N, Bara J and Burtin P: Induction of rat intestinal carcinogenesis with single doses, low and high repeated doses of 1,2-dimethylhydrazine. Carcinogenesis 10: 69-72, 1989.
22. Bara J, Gautier R, Mouradian P, Dccaens C and Daher N: Oncofetal mutin M1 epitope family: characterization and expression during colonie carcinogenesis. Int J Cancer 47: 304-310, 1991.
23. Paris AR, McEntire KD, Thompson NL and Hixson DC: Identification and characterization of a rat hepatic oncofetal membrane glycoprotein. Cancer Res 50: 4755-4763, 1990.
24. Lim YP, Fowler LC, Hixson DC, Wehbe T and Thompson NL: TuAg. 1 is the liver isoform of the rat colon tumor-associated antigen pE4 and a member of the immunoglobulin-like supergene family. Cancer Res 56: 3934-3940, 1996.
25. Moser AR, Pilot HC and Doce WF: A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247: 322-324, 1990.
26. Su LK, Kinzler W, Vogelstein B, Preisinger AC, Moser AR, Luongo C, Gould KA and Dove WF: Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256: 668-670, 1992.
27. Chadéneau C, LeCabellec M, LeMoullac B, Meflah K and Denis MG: Overexpression of a novel member of the immunoglobulin superfamily in Min mouse intestinal adenomas. Int J Cancer 68: 817-821, 1996.
28. Chadéneau C, LeMoullac B, Cornu G, Meflah K and Denis MG: Glycosylation of a novel member of the immunoglobulin gene superfamilly expressed in rat carcinoma cell lines. Int J Cancer 61: 87-91, 1995.
29. Cunningham BA, Hemperly JJ, Murray BA, Prediger EA, Brackenbury R and Edelman GM: Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation and alternative RNA splicing. Science 236: 799-806, 1987.
30. Parekh RB, Tse AG, Dwek RA, Williams AF and Rademacher TW: Tissue-specific N-glycosylation, site-specific oligosaccharide patterns and lentil Iectin recognition of rat Thy-1. EMBO J 6: 1233-1244, 1987.
31. Chadéneau C, LeMoullac B and Denis MG: A novel member of the immunoclobulin gene superfamilly expressed in colon tumors. J Biol Chem 269: 15601-15605, 1994.
32. Altschul SF, Gish W, Miller W, Myers EW and Lipman DJ: Basic local alignment tool. J Mol Biol 215: 403-410, 1990.
33. Mendelsohn CL, Wimmer E and Racaniello VR: Cellular receptor for poliovirus: molecular cloning, nucleotide sequence and expression of a new member of the immunoglobulin superfamily. Cell 56: 855-865, 1989.
34. Koike S, Ise I, Sato Y, Yonekawa H, Gotoh O and Nomoto A: A second gene for the African green monkey poliovirus receptor that has no putative N-glycosylation site in the functional immunoglobulin-like domain. J Virol 66: 7059-7066, 1992.
35. Eberle F, Dubreuil P, Mattel MG, Devilard E and Lopez M: The human PRR2 gene, related to the human poliovirus receptor gene (PVR), is the true homolog of the murine MPH gene. Gene 159: 267-272, 1995.
36. Williams AF and Barclay AN: The immunoglobulin superfamily-domains for cell surface recognition. Annu Rev Immunol 6: 381-405, 1988.
37. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W and Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402, 1997.
38. Chadéneau C, Liehr T, Rautenstrauss B and Denis MG: The Tage4 gene maps to rat chromosome Iq22. Mamm Genome 8: 157-158, 1997.
39. Chadéneau C, LeMoullac B, LeCabellec M, Mattei MG, Meflah K and Denis MG: Isolation and chromosomal localization of mE4, a novel murine gene of the immunoglobulin superfamily. Mamm Genome 7: 636-637, 1996.
40. Thompson J, Zimmermann W, Nollau P, Neumaier M, Weber-Arden J, Schrewe H, Craig I and Willcocks T: CGM2, a member of the carcinoembryonic antigen gene family is down-regulated in colorectal carcinomas. J Biol Chem 269: 32924-32931, 1994.
41. Neumaier M, Paululat S, Chan A, Matthaes P and Wagener C: Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorcctal carcinomas. Proc Natl Acad Sci USA 90: 10744-10748, 1993.
42. Mafune K, Saini KS, Ravikumar TS, Chen LB, Steele GD and Thomas P: Differences in messenger RNA expression of carcino-embryonic antigen in surgical specimens of colorectal carcinoma. Tumour Biol 13: 330-337, 1992.
43. Chi KF, Jessup JM and Frazier ML: Predominant expression of mRNA coding for non-specific cross-reacting antigen in colorectal carcinomas. Tumour Biol 12: 298-308, 1991.
44. Sun J, Thurin J, Cooper HS, Wang P, MacKiewicz M, Steplewki Z and Blaszczyk-Thurin M: Elevated expression of H type GDP-L-fucose: beta-D-galactoside alpha-2-L-fucosyl-transferase is associated with human colon adenocarcinoma progression. Proc Natl Acad Sci USA 92: 5724-5728, 1995.
45. Edelman GM: Morphoregulatory molecules. Biochemistry 27: 3533-3543, 1988.
46. Burgoon MP, Grumet M, Mauro V, Edelman GM and Cunningham BA: Structure of the chicken neuron-glia cell adhesion molecule, Ng-CAM: origin of the polypeptides and relation to the Ig superfamily. J Cell Biol 112: 1017-1029, 1991.
47. Springer TA: Adhesion receptors of the immune system. Nature 346: 425-434, 1990.
48. Dustin ML and Springer TA: Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol 107: 321-331, 1988.
49. Wawryk SO, Novotny JR, Wicks IP, Wilkinson D, Maher D, Salvaris E, Welch K, Fecondo J and Boyd AW: The role of the LFA-1/ICAM-1 interaction in human leukocyte homing and adhesion. Immunol Rev 108: 135-161, 1989.
50. Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler ME and Lobb RR: VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60: 577-584, 1990.
51. Aoki J, Koike S, Asou H, Ise I, Suwa H, Tanaka T, Miyasaka M and Nomoto A: Mouse homolog of poliovirus receptor-related gene 2 product, mPRR2, mediates homophilic cell aggregation. Exp Cell Res 235: 374-384, 1997.
52. Brackenbury R: Molecular mechanisms of cell adhesion in normal and transformed cells. Cancer Metastasis Rev 4: 41-58, 1985.
53. Martin-Padura I, Mortarini R, Lauri D, Bernasconi S, Sanchez-Madrid F, Parmiani G, Mantovani A, Anichini A and Dejana E: Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression. Cancer Res 51: 2239-2241, 1991.
54. Taichman DB, Cybulsky MI, Djaffar I, Longenecker BM, Teixido J, Rice GE, Aruffo A and Bevilacqua MP: Tumor cell surface alpha 4 beta 1 integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of 1NCAM-110/VCAM-1. Cell Regul 2: 347-355, 1991.
55. Tang DG, Chen YQ, Newman PJ, Shi L, Gao X, Diglio CA and Honn KV: Identification of PECAM-1 in solid tumor cells and its potential involvement in tumor cell adhesion to endothelium. J Biol Chem 268: 22883-22894, 1993.
56. Johnson JP, Stade BG, Holzmann B, Schwable W and Riethmuller G: De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci USA 86: 641-644, 1989.
57. Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K and Stanners CP: Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 57: 327-334, 1989.
58. Turbide C, Rojas M, Stanners CP and Beauchemin N: A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. J Biol Chem 266: 309-315, 1991.
59. Hedrick L, Cho KR, Boyd J, Risinger J and Vogelstein B: DCC: a tumor suppressor gene expressed on the cell surface. Cold Spring Harb Symp Quant Biol 57: 345-351, 1992.
60. Hedrick L, Cho KR, Fearon ER, Wu TC, Kinzler KW and Vogelstein B: The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes Dev 8: 1174-1183, 1994.
61. Cho KR and Fearon ER: DCC: linking tumor suppressor genes and altered cell surface interactions in cancer? Curr Opin Genet Dev 5: 72-78, 1995.
62. Kikuchi-Yanoshita R, Konishi M, Fukunari H, Tanaka K and Miyaki M: Loss of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res 52: 3801-3803, 1992.
63. Cho KR, Oliner JD, Simons JW, Hedrick L, Fearon ER, Preisinger AC, Hedge P, Silverman GA and Vogelstein B: The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics 19: 525-531, 1994.
64. White JM and Littman DR: Viral receptors of the immunoglobulin superfamily. Cell 56: 725-728, 1989.
65. Mendelsohn CL, Wimmer E and Racaniello VR: Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56: 855-865, 1989.
66. Bernhardt G, Bibb JA, Bradley J and Wimmer E: Molecular characterization of the cellular receptor for poliovirus. Virology 199: 105-113, 1994.
67. Greve JM, Davis G, Meyer AM, Forte CP, Yost SC, Marlor CW, Kamarck ME and McClelland A: The major human rhinovirus receptor is ICAM-1. Cell 56: 839-847, 1989.
68. Staunton DE, Merluzzi VJ, Rothlein R, Barton R, Marlin SD and Springer TA: A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 56: 849-853, 1989.
69. Yarden Y, Escobedo JA, Kuang WJ, Yang-Feng TL, Daniel TO, Tremble PM, Chen EY, Ando ME, Harkins RN, Francke U, Fried VA, Ullrich A and Williams LT: Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature 323: 226-232, 1986.
70. Coussens L, Van Beveren C, Smith D, Chen E, Mitchell RL, Isacke CM, Verma IM and Ullrich A: Structural alteration of viral homologue of receptor proto-oncogene fins at carboxyl terminus. Nature 320: 277-280, 1986.
71. Sherr CJ, Roussel MF and Rettenmier CW: Colony-stimulating factor-1 receptor (c-fms). J Cell Biochem 38: 179-187, 1988.
72. Givol D and Yayon A: Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J 6: 3362-3369, 1992.
73. Chellaiah AT, McEwen DG, Werner S, Xu J and Ornitz DM: Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1. J Biol Chem 269: 11620-11627, 1994.
74. Cheon HG, Larochelle WJ, Bottaro DP, Burgess WH and Aaronson SA: High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains. Proc Natl Acad Sci USA 91: 989-993, 1994.
75. Campbell IG, Foulkes WD, Senger G, Trowsdale J, Garin-Chesa P and Rettig WJ: Molecular cloning of the B-CAM cell surface glycoprotein of epithelial cancers: a novel member of the immunoglobulin superfamily. Cancer Res 54: 5761-5765, 1994.
76. Kleinerman DI, Troncoso P, Lin SH, Pisters LL, Sherwood ER, Brooks T, Von Eschenbach AC and Hsieh JT: Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: implication as a tumor suppressor. Cancer Res 55: 1215-1220, 1995.
77. Lehmann JM, Riethmuller G and Johnson JP: MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc Natl Acad Sci USA 86: 9891-9895, 1989.
78. Johnson JP, Rothbacher U and Sers C: The progression associated antigen MUC18: a unique member of the immunoglobulin supergene family. Melanoma Res 3: 337-340, 1993.
79. Littman DR: The structure of the CD4 and CD8 genes. Annu Rev Immunol 5: 561-584, 1987.